ELEKTA’S TECH PROWESS NEEDS THE BACKING OF A NEW CEO (BUY; 69% UPSIDE)
13/03/25 -" Since our March 2024 idea kicker for family-controlled Elekta (Buy; Sweden) entitled ELEKTA'S CINDERELLA STORY HAS A LONG WAY TO GO, the situation has deteriorated for this leading provider of ..."
Pages
64
Language
English
Published on
13/03/25
You may also be interested by these reports :
27/02/26
bioMerieux’s Q4 sales met expectations, with top-line growth driven by both segments. Management fulfilled its 2025 commitments and provided 2026 ...
25/02/26
Even though Q4 sales and profitability missed consensus, the markets seem happy with the 2026 outlook. Q4 performance was underpinned by healthy ...
25/02/26
Fresenius delivered solid Q4 25 results, supported by broad-based growth across Kabi and Helios. Biopharma remained the key growth engine, supported ...
24/02/26
FMC delivered a strong Q4 profit beat, with record profitability driven by accelerated FME25+ savings and operational discipline. FY 25 results also ...